FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112727488> ?p ?o ?g. }

• W3112727488 endingPage "765" @default.
• W3112727488 startingPage "765" @default.
• W3112727488 abstract "Broadly neutralizing antibodies (bnAbs) isolated from HIV-infected individuals delineate vulnerable sites on the HIV envelope glycoprotein that are potential vaccine targets. A linear epitope within the N-terminal region of the HIV-1 fusion peptide (FP8) is the primary target of VRC34.01, a bnAb that neutralizes ~50% of primary HIV isolates. FP8 has attracted attention as a potential HIV vaccine target because it is a simple linear epitope. Here, platform technologies based on RNA bacteriophage virus-like particles (VLPs) were used to develop multivalent vaccines targeting the FP8 epitope. Both recombinant MS2 VLPs displaying the FP8 peptide and Qβ VLPs displaying chemically conjugated FP8 peptide induced high titers of FP8-specific antibodies in mice. Moreover, a heterologous prime-boost-boost regimen employing the two FP8-VLP vaccines and native envelope trimer was the most effective approach for eliciting HIV-1 neutralizing antibodies. Given the potent immunogenicity of VLP-based vaccines, this vaccination strategy—inspired by bnAb-guided epitope mapping, VLP bioengineering, and prime-boost immunization approaches—may be a useful strategy for eliciting bnAb responses against HIV." @default.
• W3112727488 created "2020-12-21" @default.
• W3112727488 creator A5001206769 @default.
• W3112727488 creator A5014101361 @default.
• W3112727488 creator A5021680253 @default.
• W3112727488 creator A5024920180 @default.
• W3112727488 creator A5040521219 @default.
• W3112727488 creator A5042543645 @default.
• W3112727488 creator A5043677118 @default.
• W3112727488 creator A5046608991 @default.
• W3112727488 creator A5047326687 @default.
• W3112727488 creator A5047929823 @default.
• W3112727488 creator A5070087777 @default.
• W3112727488 creator A5071657202 @default.
• W3112727488 creator A5074096399 @default.
• W3112727488 date "2020-12-15" @default.
• W3112727488 modified "2023-10-01" @default.
• W3112727488 title "Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide" @default.
• W3112727488 cites W1967006002 @default.
• W3112727488 cites W1968134508 @default.
• W3112727488 cites W1975983467 @default.
• W3112727488 cites W1977952292 @default.
• W3112727488 cites W1978398372 @default.
• W3112727488 cites W1979742563 @default.
• W3112727488 cites W1987519563 @default.
• W3112727488 cites W1990030292 @default.
• W3112727488 cites W2007622060 @default.
• W3112727488 cites W2010959676 @default.
• W3112727488 cites W2028501030 @default.
• W3112727488 cites W2039472971 @default.
• W3112727488 cites W2052111709 @default.
• W3112727488 cites W2069068211 @default.
• W3112727488 cites W2069871552 @default.
• W3112727488 cites W2070086938 @default.
• W3112727488 cites W2079495811 @default.
• W3112727488 cites W2086463570 @default.
• W3112727488 cites W2106474364 @default.
• W3112727488 cites W2138875004 @default.
• W3112727488 cites W2141211628 @default.
• W3112727488 cites W2144855070 @default.
• W3112727488 cites W2146700406 @default.
• W3112727488 cites W2152048324 @default.
• W3112727488 cites W2161609692 @default.
• W3112727488 cites W2193557615 @default.
• W3112727488 cites W2201508340 @default.
• W3112727488 cites W2289942604 @default.
• W3112727488 cites W2334437992 @default.
• W3112727488 cites W2380132702 @default.
• W3112727488 cites W2408284918 @default.
• W3112727488 cites W2515557558 @default.
• W3112727488 cites W2515956381 @default.
• W3112727488 cites W2553045059 @default.
• W3112727488 cites W2578371477 @default.
• W3112727488 cites W2597018254 @default.
• W3112727488 cites W2682456409 @default.
• W3112727488 cites W2753483322 @default.
• W3112727488 cites W2754267804 @default.
• W3112727488 cites W2770988077 @default.
• W3112727488 cites W2777283909 @default.
• W3112727488 cites W2783088490 @default.
• W3112727488 cites W2798456210 @default.
• W3112727488 cites W2799119185 @default.
• W3112727488 cites W2804815996 @default.
• W3112727488 cites W2891594162 @default.
• W3112727488 cites W2911813404 @default.
• W3112727488 cites W2915251485 @default.
• W3112727488 cites W2938562409 @default.
• W3112727488 cites W2948588867 @default.
• W3112727488 cites W2951936481 @default.
• W3112727488 cites W4239659366 @default.
• W3112727488 doi "https://doi.org/10.3390/vaccines8040765" @default.
• W3112727488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7765226" @default.
• W3112727488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33333740" @default.
• W3112727488 hasPublicationYear "2020" @default.
• W3112727488 type Work @default.
• W3112727488 sameAs 3112727488 @default.
• W3112727488 citedByCount "10" @default.
• W3112727488 countsByYear W31127274882021 @default.
• W3112727488 countsByYear W31127274882022 @default.
• W3112727488 countsByYear W31127274882023 @default.
• W3112727488 crossrefType "journal-article" @default.
• W3112727488 hasAuthorship W3112727488A5001206769 @default.
• W3112727488 hasAuthorship W3112727488A5014101361 @default.
• W3112727488 hasAuthorship W3112727488A5021680253 @default.
• W3112727488 hasAuthorship W3112727488A5024920180 @default.
• W3112727488 hasAuthorship W3112727488A5040521219 @default.
• W3112727488 hasAuthorship W3112727488A5042543645 @default.
• W3112727488 hasAuthorship W3112727488A5043677118 @default.
• W3112727488 hasAuthorship W3112727488A5046608991 @default.
• W3112727488 hasAuthorship W3112727488A5047326687 @default.
• W3112727488 hasAuthorship W3112727488A5047929823 @default.
• W3112727488 hasAuthorship W3112727488A5070087777 @default.
• W3112727488 hasAuthorship W3112727488A5071657202 @default.
• W3112727488 hasAuthorship W3112727488A5074096399 @default.
• W3112727488 hasBestOaLocation W31127274881 @default.
• W3112727488 hasConcept C104317684 @default.
• W3112727488 hasConcept C159047783 @default.
• W3112727488 hasConcept C159654299 @default.

• next